Molina Healthcare - MOH Stock Forecast, Price & News

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Analysts Set New Price Targets

Several brokerages recently weighed in on MOH. Deutsche Bank Aktiengesellschaft increased their price objective on Molina Healthcare from $311.00 to $315.00 in a research report on Monday, August 1st. Credit Suisse Group set a $321.00 price objective on Molina Healthcare in a research report on Tuesday, July 19th. Wells Fargo & Company lowered their price objective on Molina Healthcare from $308.00 to $301.00 and set an "underweight" rating for the company in a research report on Wednesday, May 25th. Cowen increased their price objective on Molina Healthcare from $356.00 to $366.00 in a research report on Monday, May 2nd. Finally, Loop Capital began coverage on Molina Healthcare in a research report on Thursday, June 16th. They issued a "hold" rating and a $310.00 price objective for the company. Two analysts have rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $341.00.

Molina Healthcare Trading Up 0.3 %

MOH opened at $333.39 on Tuesday. Molina Healthcare has a 52 week low of $245.72 and a 52 week high of $350.19. The business has a fifty day simple moving average of $292.69 and a 200-day simple moving average of $307.91. The firm has a market cap of $19.37 billion, a P/E ratio of 25.96, a P/E/G ratio of 1.15 and a beta of 0.85. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.84.

Molina Healthcare (NYSE:MOH - Get Rating) last announced its quarterly earnings data on Wednesday, July 27th. The company reported $4.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.34 by $0.21. The business had revenue of $8.05 billion for the quarter, compared to analysts' expectations of $7.69 billion. Molina Healthcare had a return on equity of 32.97% and a net margin of 2.48%. The company's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the firm earned $3.40 earnings per share. On average, equities analysts expect that Molina Healthcare will post 17.63 earnings per share for the current year.

Insider Activity

In other news, insider Jeff D. Barlow sold 90 shares of the stock in a transaction on Tuesday, August 9th. The stock was sold at an average price of $333.01, for a total value of $29,970.90. Following the sale, the insider now directly owns 81,146 shares in the company, valued at $27,022,429.46. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, insider Jeff D. Barlow sold 90 shares of the stock in a transaction on Tuesday, August 9th. The stock was sold at an average price of $333.01, for a total value of $29,970.90. Following the sale, the insider now directly owns 81,146 shares in the company, valued at $27,022,429.46. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Dale B. Wolf sold 2,000 shares of the firm's stock in a transaction on Tuesday, August 2nd. The shares were sold at an average price of $327.99, for a total value of $655,980.00. Following the completion of the sale, the director now owns 11,824 shares in the company, valued at $3,878,153.76. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,826 shares of company stock worth $13,089,848. Corporate insiders own 1.60% of the company's stock.